Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH) -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (102)	1/26/1998 5:09:00 PM
From: Sigmund	Read Replies (1) \| Respond to of 178

At this point I am out so it is only of academic interest to me now. It looked to me that $16 was a resistance point and when this cracked there was no bottom for a long time. Possibly some people will do real well now, but I didn't want to take this risk anymore. I still think they will get approval but only time will tell. Not much time at that. I think if they get approval it will be good for the entire sector including ACMI. I heard that some broker was negative on CYTC this a.m. I imagine that CYTC will soon issue earnings. I think that NPTH will report on earnings on Thursday if I have that correct. So there will be much sector related earnings news out probably a lot of it not so good. After that if NPTH does get approval maybe the sector will fare better.